(Q33592137)

English

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial (English)

1 reference

Europe PubMed Central

28 July 2017

1 reference

based on heuristic

inferred from title

bullous pemphigoid

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Hywel C Williams

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Fenella Wojnarowska

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Gudula Kirtschig

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Thomas R Godec

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Joanne R Chalmers

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Margaret Childs

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Shernaz Walton

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Karen Harman

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Anna Chapman

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Diane Whitham

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Andrew J Nunn

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

UK Dermatology Clinical Trials Network BLISTER Study Group

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

0 references

publication date

6 March 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

389

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

10079

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1630-1638

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

A population-based study of the association between bullous pemphigoid and neurologic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Pemphigoid diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Clinical applications of non-antimicrobial tetracyclines in dermatology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Interventions for bullous pemphigoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Nicotinamide and tetracycline therapy of bullous pemphigoid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Pharmacology and toxicology of doxycycline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

The events leading to the death of patients with pemphigus and pemphigoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

21 June 2018

Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyc

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

The associations between bullous pemphigoid and drug use: a UK case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5400809

30 October 2018

Incidence and Mortality of Bullous Pemphigoid in France

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignancies in pemphigus and pemphigoid diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The approach of dermatologists in the UK to the treatment of bullous pemphigoid: results of a national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma exchange in bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of adherence to topical corticosteroids in patients with bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxycycline in the treatment of bullous pemphigoid: as good as systemic corticosteroids?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2930560-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(17)30560-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28279484%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33592137&oldid=1531662997"